Roth MKM analyst maintained a Buy rating on Biohaven Ltd. today and set a price target of $30.00. The company’s shares opened today at $13.66.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Currently, the analyst consensus on Biohaven Ltd. is a Strong Buy with an average price target of $43.30, a 216.98% upside from current levels. In a report released today, Robert W. Baird also maintained a Buy rating on the stock with a $52.00 price target.
The company has a one-year high of $55.70 and a one-year low of $12.79. Currently, Biohaven Ltd. has an average volume of 2.11M.
Read More on BHVN:
- 3 Best Stocks to Buy Now, 8/12/2025, According to Top Analysts
- Biohaven price target lowered to $50 from $60 at Leerink
- Biohaven price target lowered to $52 from $57 at Baird
- Biohaven price target lowered to $49 from $50 at BofA
- Biohaven Ltd.: Strategic Shift and Upcoming Milestones Justify Buy Rating Despite Setbacks